TSX:ACB Investor takeaway https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/aurora-reveals-cannabis-retail-strategy/
Investor takeaway
Canaccord Genuity analyst Matt Bottomley issued a research note on Aurora following the MedReleaf acquisition. In his note, the analyst stamped the company with a price target of C$11 and reiterated his “buy” recommendation on the stock.
Aurora’s share price spiked early during Wednesday’s trading session, reaching a day high price of C$6.40. However, the cannabis producer decreased as the day continued and closed at C$6.18, representing a marginal 0.32-percent increase to its share price.
Alcanna enjoyed a more stable jump, rising 3.27 percent to reach a price point of C$9.48.